Sulfonated Amphiphilic Poly(α)glutamate Amine—A Potential siRNA Nanocarrier for the Treatment of Both Chemo-Sensitive and Chemo-Resistant Glioblastoma Tumors
Authors:
- Adva KrivitskyAKAdva Krivitsky
- Sabina PozziSPSabina Pozzi
- Eilam YeiniEYEilam Yeini
- Sahar Israeli DangoorSDSahar Israeli Dangoor
- Tal ZurTZTal Zur
- Sapir GolanSGSapir Golan
- Vadim KrivitskyVKVadim Krivitsky
- Nitzan AlbeckNANitzan Albeck
- Evgeny PisarevskyEPEvgeny Pisarevsky
- Paula OfekPOPaula Ofek
- Asaf MadiAMAsaf Madi
- Ronit Satchi-FainaroRonit Satchi-Fainaro
Open Access
- 20 December 2021
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (12) , 2199
Abstract
Development of chemo-resistance is a major challenge in glioblastoma (GB) treatment. This phenomenon is often driven by increased activation of genes associated with DNA repair, such as the alkyl-removing enzyme O6-methylguanine-DNA methyltransferase (MGMT) in combination with overexpression of canonical genes related to cell proliferation and tumor progression, such as Polo-like kinase 1 (Plk1). Hereby, we attempt to sensitize resistant GB cells using our established amphiphilic poly(α)glutamate (APA): small interfering RNA (siRNA) polyplexes, targeting Plk1. Furthermore, we improved brain-targeting by decorating our nanocarrier with sulfonate groups. Our sulfonated nanocarrier showed superior selectivity towards P-selectin (SELP), a transmembrane glycoprotein overexpressed in GB and angiogenic brain endothelial cells. Self-assembled polyplexes of sulfonated APA and siPlk1 internalized into GB cells and into our unique 3-dimensional (3D) GB spheroids inducing specific gene silencing. Moreover, our RNAi nanotherapy efficiently reduced the cell viability of both chemo-sensitive and chemo-resistant GB cells. Our developed sulfonated amphiphilic poly(α)glutamate nanocarrier has the potential to target siRNA to GB brain tumors. Our findings may strengthen the therapeutic applications of siRNA for chemo-resistant GB tumors, or as a combination therapy for chemo-sensitive GB tumors.Keywords
Funding Information
- European Research Council (835227)
This publication has 37 references indexed in Scilit:
- Administration, distribution, metabolism and elimination of polymer therapeuticsJournal of Controlled Release, 2012
- Selectins promote tumor metastasisSeminars in Cancer Biology, 2010
- Targeting Angiogenesis-Dependent Calcified Neoplasms Using Combined Polymer TherapeuticsPLOS ONE, 2009
- Chemotherapy Delivery Issues in Central Nervous System Malignancy: A Reality CheckJournal of Clinical Oncology, 2007
- Targeting polo-like kinase 1 for cancer therapyNature Reviews Cancer, 2006
- MGMTGene Silencing and Benefit from Temozolomide in GlioblastomaNew England Journal of Medicine, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Synthesis and polymerization of methacryloyl-PEG-sulfonic acid as a functional macromer for biocompatible polymeric surfacesMacromolecular Research, 2004
- Tyrosine Sulfation of P-selectin Glycoprotein Ligand-1 Is Required for High Affinity Binding to P-selectinJournal of Biological Chemistry, 1995
- Inflammatory roles of P-selectin.Journal of Clinical Investigation, 1993